Streetbeat News

Earnings

FDS

FactSet Research Systems (FDS) shares are trading lower despite the company reporting better-than-expected Q2 sales results.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 1:47 pm

KIRK

Kirkland's Inc (NASDAQ:KIRK) shares rose after reporting Q4 FY23 results with revenue of $165.9 million, slightly below consensus but with significant improvements in gross profit margin, adjusted EBITDA, and EPS. The company highlighted growth in same-store sales, a reduction in e-commerce sales decline, and benefits from strategic repositioning initiatives. Kirkland's ended the quarter with net income of $10.1 million, a turnaround from the previous year's loss, and reported $40.0 million in outstanding debt.

Portfolio Pulse from Lekha Gupta

March 21, 2024 | 1:46 pm

SPY

The S&P Global Services PMI for March was reported at 51.7, falling short of the estimated 52.0 and the previous month's 52.3, indicating a slight slowdown in the services sector.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 1:45 pm

LABP

Landos Biopharma (NASDAQ:LABP) reported Q4 earnings with an EPS of $-0.99, missing estimates by -9.0% and showing no revenue change from the previous year. The company's past earnings miss led to a 7% drop in share price the following day.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 1:40 pm

FIVE

MU

SMH

SPY

Semiconductor stocks, including the ETF SMH, gained following positive developments from Micron (MU). Five Below (FIVE) experienced a decline after its earnings report. Overall, stock indexes, represented by SPY, increased after the Federal Reserve's decision.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 1:37 pm

BNOX

Bionomics Limited (NASDAQ:BNOX) released detailed data from its Phase 2b ATTUNE trial of BNC210 for PTSD, showing significant improvements in primary and several secondary endpoints. The trial demonstrated BNC210's efficacy in reducing PTSD symptoms, depressive symptoms, and improving sleep, with a favorable safety profile. Bionomics plans to discuss these results with the FDA in Q2 2024 and proceed to a late-stage trial in Q4 2024. Following the news, BNOX shares experienced volatility, dropping 1.09% to $1.03 after initially spiking to $1.30 in premarket trading.

Portfolio Pulse from Vandana Singh

March 21, 2024 | 1:36 pm

SWKH

SWK Holdings (NASDAQ:SWKH) reported Q4 earnings with an EPS of $0.23, missing estimates by -23.0% against an expected $0.3. Revenue increased by $93 thousand year-over-year. Previously, the company had beaten EPS estimates in Q3 2023, which led to a 1.0% share price increase the following day.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 1:35 pm

KRON

Kronos Bio (NASDAQ:KRON) reported Q4 earnings with an EPS of $-0.43, beating estimates by 17.0% against an expected $-0.52. Revenue increased by $2.29 million from the previous year. Despite beating estimates this quarter, a miss in the last quarter led to a 1.0% drop in share price the following day.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 1:35 pm

LUCD

PAVM

Lucid Diagnostics Inc. (LUCD) and its majority-owned parent company PAVmed Inc. (PAVM) announced positive results from the first prospective clinical validation study of EsoGuard, a test for esophageal precancer detection. Conducted at the Louis Stokes Cleveland Veterans Affairs Medical Center, the study showed EsoGuard's sensitivity at 92.9% and negative predictive value at 98.6%. These results, along with previous studies, support EsoGuard's use as a screening tool for esophageal precancer and cancer, potentially leading to broader medical policy coverage and CMS coverage.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 1:31 pm

PYXS

Pyxis Oncology (NASDAQ:PYXS) reported Q4 earnings, beating estimates with an EPS of $-0.33 against an expected $-0.47. However, revenue remained unchanged from the previous year. This follows a quarter where the company missed EPS estimates, leading to a 2% share price drop.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 1:30 pm